Tata Chemicals Limited has announced a conference call for analysts and investors to discuss its financial performance for the third quarter and nine months ended December 31, 2025. The call is scheduled for Monday, February 2, 2026, at 7:00 PM IST, as communicated to the stock exchanges on January 21, 2026.

Earnings Call Details

The conference call will focus on the company's unaudited consolidated and audited standalone financial results for Q3 and 9M FY26. The announcement was made pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Management Participation

The earnings call will be represented by senior leadership from Tata Chemicals Limited:

• R Mukundan - Managing Director & CEO
• Nandakumar Tirumalai - Chief Financial Officer

The call will commence with key comments from the management team, followed by an interactive Question & Answer session where participants can pose queries to the management.

Company Information

Tata Chemicals Limited operates as a global company in Basic Chemistry and Specialty Products. The company's shares are listed on both BSE Limited (Scrip Code: 500770) and National Stock Exchange of India Ltd (Symbol: TATACHEM).

Contact Information

For additional information regarding the earnings call, participants can contact:

• Damini Jhunjhunwala / Chintan Joshi
• Phone: +91 22 6232 7400
• Email: djhunjhunwala@tatachemicals.com / chjoshi@tatachemicals.com

The intimation has been made available on the company's website at www.tatachemicals.com , and the announcement was signed by Jeraz E. Mahernosh, Company Secretary (FCS 7008), on January 21, 2026.

Tata Chemicals Limited has announced significant changes in its senior management personnel structure, effective February 1, 2026. The company made this disclosure on January 14, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Leadership Transitions

The management restructuring involves multiple senior positions across the organization. The changes reflect both planned retirements and strategic appointments to strengthen the company's leadership team.

Succession Planning and Strategic Appointments

The most significant transition involves the Chief Commercial Officer position. K. R. Venkatadri, the current Chief Commercial Officer, will superannuate on March 31, 2026, following the company's retirement policy. To ensure smooth transition, Alok Chandra, currently serving as Chief – HSE, has been designated as Chief Commercial Officer (Designate) effective February 1, 2026, and will formally assume the Chief Commercial Officer role from April 1, 2026.

New Leadership Roles

The company has created two new senior management positions to enhance its operational capabilities. Narasimha V. Kamath will take on the role of Chief Safety, Sustainability & Manufacturing Officer (CSSMO), while Rajesh Kamat will serve as Chief Strategy & Projects Officer (CSPO). Both appointments are effective from February 1, 2026.

Regulatory Compliance

The announcement was made through a formal communication to both BSE Limited and National Stock Exchange of India Limited. The disclosure was signed by Company Secretary Jeraz E. Mahernosh and submitted in accordance with SEBI Master Circular dated November 11, 2024. The company's scrip code on BSE is 500770, while its symbol on NSE is TATACHEM.

These management changes represent Tata Chemicals' commitment to maintaining strong leadership continuity while adapting its organizational structure to meet evolving business requirements.